Conference News
2023
2022
2021
2020
2019
2018
2017
2016
Endovastec™ Presents Flagship Products at CICE 2022
04 Jul 2022
Recently, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”) held a seminar at the International Congress of Endovascular Surgery (Congresso International de Cirurgia Endovascular, CICE 2022) in Brazil, engaging local and global experts.
Endovastec™ Holds Virtual Launch Meeting for Fontus™ Branched Surgical Stent Graft System
28 Apr 2022
Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) recently hosted a product launch event titled “Elephant trunk for the heart: revival of the classic” for its Fontus™ Branched Surgical Stent Graft System (Fontus™), which was held back-to-back with a seminar on the stented elephant trunk procedure. Twenty-one experts from 17 hospitals gathered virtually to share clinical data and information related to the application of Fontus™, which attracted the attendance of over 5,000 viewers online.
“Beyond the Road, Aortic Forum" International Aortic Forum Series Report
01 Sept 2019
Shanghai, China – Recently, the 4th “Beyond the Road, Aortic Forum” was successfully held by Shanghai MicroPort Endovascular MedTech Co., Ltd. (“Endovastec™”, or “the Company”). There are 11 doctors from Argentina participated in this forum. Under the support from the top clinical centers on the field of aortic disease treatment in China, this forum aims to provide a long-term learning and communication platforms for overseas doctors in cardiac surgery and vascular surgery.
Attends National Continuing Education Classes of China Endovascular Course 2018 (CEC2018)
19 Jan 2019
Shanghai, China – The National Continuing Education Classes of China Endovascular Course 2018 (CEC 2018) was recently held at the Shanghai International Convention Center in Shanghai, China. The event was jointly organized by Zhongshan Hospital Affiliated to Fudan University, Beijing Anzhen Hospital of Capital Medical University, Chinese PLA General Hospital, Cross-Strait Medicine Exchange Association, and China Research Hospital Association, with the attendance of nearly 4,000 Chinese and overseas cardiologists. Shanghai MicroPort Endovascular MedTech Co., Ltd. ("Endovastec™") presented at CEC 2018 the products of Castor® Branched Aortic Stent-Graft System ("Castor®"), Minos™ Ultra Low-Profile Stent Graft System ("Minos™"), and Reewarm™ PTX Drug Coated Balloon (Reewarm™).
MicroPort® Endovascular Held the 3rd “Beyond the Road” Aortic Forum
31 Oct 2018
Recently, the 3rd “Beyond the Road” Aortic Forum was successfully held by Shanghai MicroPort® Endovascular MedTech Co., Ltd. (hereinafter referred to as MicroPort® ENDO). The forum, on the basis of the top clinical centers for aortic disease surgical repairs in China, aims to provide a permanent didactic and exchange platform for overseas surgeons from the regions in and beyond the coverage of the Belt and Road Initiative. 8 experts from Argentina participated in this forum.
MicroPort Endovascular Held “Beyond the Road” Aortic Forum
05 Jul 2018
Beijing, China - MicroPort Endovascular (Shanghai) Co., Ltd. (“MicroPort Endovascular”) recently held the first edition of the “Beyond the Road” Aortic Forum jointly with Professor Chang Shu, who is head of the cardiovascular surgery department of Fuwai Hospital of Chinese Academy of Medical Sciences. The forum, echoing China's Belt and Road Initiative, aims to provide a permanent didactic and exchange platform for overseas surgeons from the regions in the coverage of the Belt and Road Initiative and beyond on the basis of the top clinical centers for aortic disease surgical repairs in China. Professor Danilo Kuizon from St. Luke’s Medical Center and Heart Institute in the Philippines participated in the 4-day forum.
MicroPort® Endovascular Attended Lijiang Vascular Surgery Intervention Treatment Summit
08 May 2018
Guilin, China – From May 4 to May 6, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Second Guangxi Guilin Lijiang Vascular Surgery Intervention Treatment Summit and hosted a satellite meeting. The summit focused on the latest development and hot issues of vascular surgery by expert lectures, keynote speeches, as well as debates and discussions.
MicroPort® Endovascular Attended CICE 2018
20 Apr 2018
Sao Paulo, Brazil – MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the CICE 2018 held in Sao Paulo, Brazil and invited Professor Chang Shu of Fuwai Hospital to share his clinical experience and take part in academic exchange activities such as case demonstration and academic salons in Argentina and Dominican Republic.
MicroPort® Endovascular Attended CEC 2017
01 Dec 2017
Beijing, China - MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") recently attended the 10th China Endovascular Course & 2017 National Continuing Education Program for Vascular Surgeons ("CEC 2017") that was held in the Beijing National Convention Center, to broadcast surgeries as well as host satellite meetings and academic symposiums with experts in attendance. The CEC 2017 was hosted by Beijing Anzhen Hospital of Capital Medical University, Chinese PLA General Hospital, Zhongshan Hospital of Fudan University, and Cross-Straits Medicine Exchange Association. It aims to enhance the development of basic medicine, standardize clinical operation, follow up the results of major studies and researches, and display the latest advancement in the vascular disease treatment.
MicroPort® Hosted Ninth Aortic Intervention International Forum
28 Aug 2017
Shanghai, China – From August 21 to August 25, Shanghai MicroPort Medical (Group) Co., Ltd.("MicroPort®") hosted the 9th Aorta Intervention International Forum in three cities of China including Shanghai, Beijing and Changsha. During the forum, surgeons and distributors from Argentina and Dominican Republic were invited to visit Fuwai Hospital of Chinese Academy of Medical Sciences and the Second Xiangya Hospital of Central South University for academic exchange.
MicroPort® Endovascular Attended 2017 Vascular Intervention of Peking University
21 Aug 2017
Beijing, China – From August 17 to August 20, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the 2017 Vascular Intervention of Peking University and hosted an academic salon themed on "'Ahead of the Arch' — a Discussion of the Endovascular Treatment Strategy for the Arch Disease." The conference provided an academic platform for clinicians to exchange ideas, solve puzzles and share knowledge.
MicroPort® and MicroPort® Endovascular Attended CHC 2017
15 Aug 2017
Beijing, China – From August 10 to August 13, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") and MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the 2017 China Heart Congress ("CHC 2017") & the Second China Vascular Congress ("CVC") held in China National Convention Center of Beijing and hosted a satellite meeting. The congress was hosted by Chinese Medical Association and National Center for Cardiovascular Disease and was themed "Healthy Heart • Better Life: Innovation, Translation, and Cooperation."
MicroPort® Endovascular Attended the First Three Northeast Provinces Aortic Disease Interventional Treatment Summit
25 Jul 2017
Changchun, China – On July 22, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the First Three Northeast Provinces Aortic Disease Interventional Treatment Summit held in Changchun. Hosted by Chinese Association of Cardiovascular Surgeons and the First Hospital of Jilin University, the summit provided a platform for clinicians to exchange ideas on hot topics and difficult cases of aortic disease interventional treatment through typical case studies and special lectures.
MicroPort® Endovascular Attended SEC 2017
24 Jul 2017
Hangzhou, China – From July 6 to July 9, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the 11th China Southern Endovascular Congress ("SEC") in Hangzhou, Zhejiang Province, and hosted two academic salons focusing on aortic arch treatment strategies and suitable stent structures for different kinds of aortic diseases. Around 2,000 experts from the vascular surgery field were gathered together to discuss hot topics extensively related with vascular diseases.
MicroPort® Endovascular Attended SJVF-2017
11 Jul 2017
Shanghai, China – From June 23 to June 25, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Sixth Shanghai JiaoTong University Vascular Disease Forum ("SJVF-2017") held in Shanghai. Several renowned vascular surgery experts from home and abroad were invited to deliver speeches to reveal the latest achievement and the development trend of the vascular surgery industry in an all-round way while building a platform of communication for surgeons in attendance.
MicroPort® Endovascular Attended VEC 2017
02 Jun 2017
Beijing, China – From May 12 to May 13, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Vascular and Endovascular Conference 2017 ("VEC 2017") in Beijing for academic exchange. The conference was hosted by China International Exchange and Promotion Association for Medical and Healthcare and Vascular Surgery Physicians Association of Beijing Medical Doctor Association. During the conference, domestic renowned vascular surgery specialists were gathered to share the latest advancement and development trend of China's vascular surgery industry.
MicroPort® Endovascular Attended Sixth Northwest Vascular Forum
08 May 2017
Xi'an, China – From May 5 to May 6, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Sixth Northwest Vascular Forum & the 12th Chang'an Vascular Forum held in Xi'an and held a satellite meeting of "the Application of Unibody Stent Design in Endovascular Repair." Hosted by the First Affiliated Hospital of Xi'an Jiaotong University, the meeting invited several renowned vascular surgery specialists from China and abroad to share all-around the latest advancement and the development trend of the vascular surgery field in China.
MicroPort® Endovascular Attended the Sixth Pangu Aortic Disease Forum
17 Apr 2017
Shenzhen, China – From April 14 to April 16, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Sixth Pangu Aortic Disease Forum held in Shenzhen, Guangdong Province. The forum, chaired by Professor Lizhong Sun of Beijing Anzhen Hospital of Capital Medical University, invited over 100 aortic specialists to have in-depth discussion on the new technology, new achievement, and new development of the aortic surgery.
MicroPort® Endovascular Attended 2017 Vascular Innovative Forum
03 Apr 2017
Beijing, China – On April 1, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the 2017 Vascular Innovative Forum. The forum was hosted by the Vascular Device Branch of China Association for Medical Device Industry and the Special Committee of Vascular Medicine of Chinese Research Hospital Association, and organized by the Vascular Surgery Department of Chinese PLA General Hospital. The forum aims to provide a platform for clinical experts, policy makers, industry peers, and investors to exchange ideas on the cutting-edge technology and evidence-based medicine research related to the field of vascular diseases.
MicroPort® Endovascular Attended the Fifth Shandong (Mount Tai) Aortic Surgery Forum
13 Mar 2017
Jinan, China – On March 10, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Fifth Shandong (Mount Tai) Aortic Surgery Forum in Jinan, Shandong Province. The forum was mainly hosted by the Vascular Surgery Branch of Shandong Medical Doctor Association and the Vascular Surgery Branch of Shandong Medical Association, and organized by Shandong Provincial Hospital.
MicroPort® Endovascular Attended 8th Fuwai Aortic Diseases Treatment Symposium
16 Jan 2017
Beijing, China – From January 13 to January 15, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the 8th Fuwai Aortic Diseases Treatment Symposium held in Beijing Fuwai Hospital, and displayed several devices including CRONUS™ Surgical Stent-Graft System ("CRONUS™"), Hercules™-T Low Profile Stent Graft and delivery system ("Hercules™-T"), and Castor™ Branched Aortic Stent Graft and delivery system ("Castor™").
MicroPort® Endovascular Attended Sixth China Shenzhen International Cardiovascular Disease Forum China Cardiovascular Surgery Technique and Engineering Conference
20 Dec 2016
Shenzhen, China – From December 16 to December 18, MicroPort Endovascular (Shanghai) Co., Ltd.("MicroPort® Endovascular") attended the Sixth China Shenzhen International Cardiovascular Disease Forum & China Cardiovascular Surgery Technique and Engineering Conference in Shenzhen to display CRONUS™ Surgical Stent-Graft System ("CRONUS™") and other innovative products.
MicroPort® Endovascular Attended the Ninth China Endovascular Course 2016 National Continuing Education Program for Vascular Surgeons
08 Nov 2016
Beijing, China – From November 3 to November 6, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the Ninth China Endovascular Course & 2016 National Continuing Education Program for Vascular Surgeons ( "CEC 2016") that was held in the Beijing National Convention Center, to display its innovative products and host academic symposiums. CEC 2016 was hosted by Beijing Anzhen Hospital of Capital Medical University, Chinese PLA General Hospital, Zhongshan Hospital of Fudan University, and Cross-Straits Medicine Exchange Association.
MicroPort® Endovascular Attended ENDOVASCOLOGY 2016
17 Oct 2016
Shanghai, China – From October 13 to October 15, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the ENDOVASCOLOGY 2016 in Shanghai and hosted a satellite meeting for academic exchange on endovascular aortic repair ("EVAR"). The ENDOVASCOLOGY 2016 was hosted by Chinese Medical Doctor Association, Special Committee of Endovascology of Chinese Medical Doctor Association, and the Vascular Surgery Department of Changhai Hospital of the Second Military Medical University, with more than 2,000 experts and scholars from China, US, Europe, Australia, Japan and South Korea in attendance.
MicroPort® Endovascular Attended 13th Chinese Vascular Surgery Congress
16 Aug 2016
Chengdu, China - MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") recently attended the 13th Chinese Vascular Surgery Congress of the Vascular Surgery Branch of Chinese Medical Association in Chengdu of Sichuan Province from August 11 to August 14, and displayed several innovative endovascular products. Around 1,000 domestic experts gathered together in the congress to dive deep into the application progress and prospect of drug, material, equipment and technique related with vascular surgery, with key note speeches on hot topics in the field of vascular surgery.
MicroPort® Endovascular Attended 8th Fuwai Aortic Diseases Treatment Symposium
17 Jan 2016
Beijing, China – From January 13 to January 15, MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") attended the 8th Fuwai Aortic Diseases Treatment Symposium held in Beijing Fuwai Hospital, and displayed several devices including CRONUS™ Surgical Stent-Graft System ("CRONUS™"), Hercules™-T Low Profile Stent Graft and delivery system ("Hercules™-T"), and Castor™ Branched Aortic Stent Graft and delivery system ("Castor™").
About us
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
©Copyright 1998-2020, Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2020-0065
Website record/ license No.:沪ICP备14048493号-1 HGWA Bei No.31011502014536
The registered trademarks of “微创", "MicroPort" and"" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.